This Medical Moment Episode 8 – White Space Warrior

At the age of 37, Kathy Giusti was diagnosed with Multiple Myeloma, a rare form of cancer. At the time, the disease was 100% fatal with few treatment options available. Diving deeper into her diagnosis and the disease, Kathy saw a “white space,” an opportunity to advance research and treatment for Multiple Myeloma. As a result, she founded the Multiple Myeloma Research Foundation (MMRF) in 1997.

Since its inception, the MMRF has helped accelerate the discovery of 15 new treatments for Multiple Myeloma to patients globally. Most recently, Kathy co-created the “Playbook for Cures” in conjunction with Harvard Business School and Kraft Precision Medicine Accelerator. In our latest episode of This Medical Moment, Kathy shares the secrets to her team’s success, including:

  • How to bring industry players together to create greater impact
  • Why data sharing is paramount to advancing research and treatment options
  • The importance of identifying the “white spaces” when building your mission
  • Advice for nonprofit professionals looking to change the standard of care

Never Miss a Medical Moment

The most extraordinary moments in medicine are happening right now, but will these innovations get the opportunity to change lives?

Stay in the know and be the first to watch new episodes of This Medical Moment.

Carolyn

Advancements are happening in every corner of medicine. Brilliant new innovations are upending traditional thinking and power structures in the development of treatments and the delivery of care.

Join Carolyn Morgan in This Medical Moment and learn how others are overcoming the obstacles. She will be joined by guests who are leading critical changes in the standards of care.

What’s coming next? Find out. In a moment.

Beginning May 20, 2024, the Precision Value & Health family of brands is becoming Precision AQ.

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include:
  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights. To find out more about our global services and our unified mission, to empower access to life-changing medicines for all, visit: Precision AQ

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.